1. Is the dose high enough to work for your physiology?
Tirzepatide titration starts at 2.5 mg once weekly — a dose designed primarily for tolerability, not maximum effect. The most robust weight management effects in clinical trials were observed at 10 mg and 15 mg. If you are in the first 8–12 weeks of treatment, you may simply not yet be at the dose where your appetite suppression is meaningful.
There is also genuine individual variation in dose-response. Some people see strong appetite suppression at 5 mg; others need 12.5 mg to notice a significant change in hunger signals. This is not a personal failing — it is a real pharmacological difference that your clinician can address by adjusting the titration pace.
2. Is compensatory eating offsetting the caloric deficit?
Tirzepatide suppresses appetite, but it does not prevent eating. A common pattern: the medication blunts hunger effectively, but caloric intake still exceeds output because of habitual eating (eating at fixed times regardless of hunger), reward eating (eating for emotional reasons or enjoyment rather than hunger), or caloric density of food choices.
The medication creates an opportunity to eat less — it does not guarantee that less is eaten. A food log, even a rough one maintained for two weeks, often reveals patterns that are not apparent from memory.
3. Could storage or preparation errors be degrading the medication?
Compounded tirzepatide is a peptide, and peptides are sensitive to heat, light, and improper handling. If the medication has been stored incorrectly — left at room temperature for extended periods, exposed to direct sunlight, or frozen (which can damage the molecule) — it may lose potency.
Reconstituted vials have a finite shelf life, typically 28–30 days when refrigerated. Medication that has passed this window or was stored improperly should not be used. Contact your pharmacy if you have questions about storage or shelf life.
Injection technique also matters. Subcutaneous injection delivers the peptide into the fat layer beneath the skin. Accidental intramuscular injection or injecting into scar tissue can alter absorption.
Most perceived tirzepatide “failures” trace back to dose, intake, storage, or timeline — not a medication that stopped working.
4. Does your timeline match pharmacological reality?
Tirzepatide is not a rapid-acting medication. The mechanism — suppressing appetite and improving the hormonal environment for fat mobilization — operates over weeks and months. The SURMOUNT-1 trial showed average weight reductions at 72 weeks, not at 4 weeks.
Meaningful body composition changes typically become visible in months three through six. If you are evaluating a six-week result against a six-month expectation, the medication may in fact be working — just not on the timeline social media content implies.
5. Metabolic adaptation
As body weight decreases, resting metabolic rate decreases proportionally — the body requires fewer calories to maintain the lower weight. This is metabolic adaptation: a well-documented physiological response to caloric restriction, not specific to tirzepatide. It is why weight loss slows over time even when adherence is consistent.
Plateaus are a normal feature of this process. Adding resistance training (which supports metabolically active lean mass), adjusting dietary protein intake, or working with your clinician on dose adjustments are the standard approaches to breaking a plateau.
6. An underlying condition may be limiting response
Uncontrolled hypothyroidism, polycystic ovarian syndrome (PCOS), insulin resistance, Cushing’s syndrome, certain medications (corticosteroids, some antipsychotics, antidepressants), and other conditions can make weight loss substantially harder regardless of the medication used. If you haven’t had recent labs, discussing thyroid function, cortisol, and metabolic markers with your clinician may identify a modifiable factor.
What to bring to your clinician check-in
A productive troubleshooting conversation with your clinician works best when you come prepared:
- Your current dose and how long you’ve been at that dose
- A rough estimate of weekly caloric intake, or a two-week food log if you have one
- Your storage and injection protocol
- Any recent changes in medications, stress levels, or sleep
- The specific metric that feels stalled (weight, energy, hunger suppression)
A clinician who has your clinical picture — not just your question — can distinguish between a dose that needs adjustment, a protocol that needs modification, and a workup that needs to happen.
Frequently asked questions
Why is tirzepatide not working for me?
The most common reasons tirzepatide is not working include: being on a dose that is too low for your physiology, compensatory eating that offsets the caloric deficit, storage or reconstitution errors that degrade the medication, unrealistic timelines (expecting rapid loss in weeks rather than months), metabolic adaptation, or an underlying condition like thyroid dysfunction that limits response. A clinician check-in is the right first step.
How long does it take for tirzepatide to start working?
Most people see measurable weight changes within 4–8 weeks at an effective dose. At the starting dose (2.5 mg), the effect is mild and intended to build tolerability, not maximize loss. The most robust weight management effects are typically seen at doses of 10–15 mg, which are not reached until month 3–5 of titration.
What is a weight loss plateau on tirzepatide?
A plateau is a period of several weeks where the scale does not move despite adherence to the protocol. Plateaus are a normal feature of weight management physiology — the body adapts to a lower caloric intake by reducing resting metabolic rate. They are not a sign that the medication has stopped working. Clinician-guided dose adjustment, dietary changes, or adding resistance training often break a plateau.
Can tirzepatide lose effectiveness over time?
Some people experience a reduction in appetite suppression effect at a given dose over time, which is a form of pharmacological adaptation. This is one reason the titration schedule exists — increasing the dose restores the appetite-suppressing signal. Discuss any perceived plateau with your clinician before assuming the medication has failed.
Does tirzepatide stop working after weight loss stabilizes?
Tirzepatide continues to suppress appetite and support the hormonal environment for weight management as long as it is taken. However, the rate of weight loss naturally slows as body weight decreases (less weight to lose). Many people transition to a maintenance phase rather than ongoing loss — this is expected physiology, not medication failure.